67,500 Shares in Sotera Health Company $SHC Acquired by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System purchased a new stake in Sotera Health Company (NASDAQ:SHC) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 67,500 shares of the company’s stock, valued at approximately $968,000.

Other large investors have also recently bought and sold shares of the company. Sculptor Capital LP boosted its stake in shares of Sotera Health by 57.4% during the fourth quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after purchasing an additional 7,658,200 shares in the last quarter. Sachem Head Capital Management LP raised its holdings in Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock valued at $205,418,000 after buying an additional 3,735,000 shares during the last quarter. Vanguard Group Inc. boosted its position in Sotera Health by 16.7% during the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after buying an additional 2,756,583 shares during the period. AQR Capital Management LLC boosted its position in Sotera Health by 1,206.2% during the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock worth $50,523,000 after buying an additional 2,644,831 shares during the period. Finally, Norges Bank bought a new stake in Sotera Health during the 4th quarter worth approximately $45,278,000. 91.03% of the stock is currently owned by institutional investors.

Insider Activity

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 15.36% of the stock is owned by corporate insiders.

Sotera Health Stock Performance

SHC opened at $17.93 on Monday. Sotera Health Company has a twelve month low of $10.94 and a twelve month high of $19.85. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. The company has a fifty day moving average of $15.97 and a 200-day moving average of $16.35. The stock has a market cap of $5.11 billion, a PE ratio of 43.73 and a beta of 1.76.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.01. The business had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. Sotera Health’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, sell-side analysts predict that Sotera Health Company will post 0.88 EPS for the current year.

Wall Street Analyst Weigh In

SHC has been the subject of several recent research reports. Piper Sandler restated an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Barclays lifted their price target on shares of Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. The Goldman Sachs Group started coverage on Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective for the company. Weiss Ratings lowered Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, May 21st. Finally, Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Sotera Health currently has an average rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.